title: Reduced circulating B-lymphocytes and altered B-cell compartments in patients suffering from chronic myeloid leukaemia undergoing therapy with Imatinib.
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. g.carulli@ao-pisa.toscana.it.
authors.forename: Giovanni
authors.initials: G
authors.lastname: Carulli
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Claudia
authors.initials: C
authors.lastname: Baratè
authors.affiliation: Laboratory of Clinical Pathology, Section of Flow Cytometry, Versilia Hospital, Lido di Camaiore, Italy.
authors.forename: Alessandra
authors.initials: A
authors.lastname: Marini
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Virginia
authors.initials: V
authors.lastname: Ottaviano
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Giulia
authors.initials: G
authors.lastname: Cervetti
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Giulia
authors.initials: G
authors.lastname: Fontanelli
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Guerrini
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Roberta
authors.initials: R
authors.lastname: Arici
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Valentina
authors.initials: V
authors.lastname: Guerri
authors.affiliation: Division of Pharmacology, Department of Clinical and Experimental Medicine,University of Pisa, Pisa, Italy.
authors.forename: Antonello
authors.initials: A
authors.lastname: Di Paolo
authors.affiliation: Division of Pharmacology, Department of Clinical and Experimental Medicine,University of Pisa, Pisa, Italy.
authors.forename: Marialuisa
authors.initials: M
authors.lastname: Polillo
authors.affiliation: Laboratory of Cytogenetics, AOUP, University of Pisa, Pisa, Italy.
authors.forename: Maria I
authors.initials: MI
authors.lastname: Ferreri
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Sara
authors.initials: S
authors.lastname: Galimberti
authors.affiliation: Division of Hematology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
authors.forename: Mario
authors.initials: M
authors.lastname: Petrini
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001402:B-Lymphocytes / Q000166:cytology / Q000378:metabolism*; D006801:Humans; D000068877:Imatinib Mesylate / Q000008:administration & dosage / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D000068877:Imatinib Mesylate